Authors


Pamela Koerner, PharmD, BCPS

Latest:

Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management

The specialty pharmacy marketplace has quickly become the primary dispenser of most therapies for orphan conditions.


Lee Stern, MS

Latest:

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.


Eric Shen, fourth-year PharmD candidate

Latest:

Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2

While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.


Charles H. Brown, MSPharm, RPh, CACP

Latest:

Fighting Free Radicals: Do You Need Antioxidants?

Patients may have questions about taking antioxidants.


Michele R. Wilson, MSPH

Latest:

Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease Therapies

Examination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.


Brandeis Seymore, RPh, MPBA

Latest:

Challenges of Channel Management for Specialty: Medical Benefit or Pharmacy Benefit

Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.


Verina Mansour, PharmD Candidate

Latest:

Do Statins Interfere With Clopidogrel During Platelet Therapy?

Despite data that might suggest a drug interaction, clinical significance is the deciding factor when considering therapeutic benefit over risk.


Anthony J. (Tony) Schueth, MS

Latest:

Health Information Technology: Facilitating an Evolution in Health Care

The use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.




Santa Maria Young II, PharmD Candidate

Latest:

A Closer Look at New FDA Actions: Amgen's Prolia

Amgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.



Luis N. Marenco, MD

Latest:

An Intermittent Reinforcement Platform to Increase Adherence to Medications

An automated reinforcement platform was shown to increase statin adherence by 34.6%.


Lawrence Baruch, MD

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.




Joni Kripal, MS, MBA

Latest:

Introduction to the Hospital-Acquired Condition Reduction Program for Pharmacy

This manuscript addresses pharmacist understanding of and/or involvement with the Hospital-Acquired Condition Reduction Program (HACRP) at their institutions.


Munder Zagaar, PharmD, PhD

Latest:

Medication Nonadherence in the Latino Population: A Challenge and an Opportunity for Specialized Services

As US demographics steadily shift towards minorities and immigrants from diverse backgrounds, health care workers must be prepared to face new cultural challenges that may impact health behaviors, including medication adherence in these populations.



Stacy B. Menees, MD

Latest:

US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic Constipation

The perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.



Catherine Misquitta, PharmD, MBA, BCPS, BCGP, FCSHP

Latest:

Three Challenges in Medication Adherence That Can Be Overcome by Pharmacists

Medication nonadherence results in greater health care spending and poorer patient health outcomes.


Kelly Mathews, PharmD

Latest:

University Partnerships: Empowering the Next Generation of Pharmacists

Corporate and academic partnerships help prepare new graduates for the world of specialty pharmacy.


Sara Karlovitch Assistant Editor

Latest:

Combining a Passion for Making a Difference With Entrepreneurship

Directions in Oncology Pharmacy® talks to Gordon Vanscoy, PharmD, MBA, CACP, recently named a national Entrepreneur of the Year for 2020 by Ernst & Young.


Khalid Eljaaly, PharmD, CAPPS, BCPS, MS

Latest:

Penicillin Allergies and Cross-Reactivity With Other Beta-Lactams

Patient-reported allergy to penicillin antibiotics is a common scenario during health care encounters, with an estimated population prevalence of roughly 8% to 12%.


Marise Khalil, PharmD Candidate 2020

Latest:

Pharmacists Can Play Key Role in Drug Repurposing

Pharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.



Vidal Essebag, MD, PhD

Latest:

Economic Burden of Atrial Fibrillation: Implications for Intervention

Because the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.


Robert R. Verbrugge, PhD

Latest:

Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid Arthritis

For patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.